Adiposity and Outcomes of Clinically Localized Prostate Cancer
肥胖和临床局限性前列腺癌的结果
基本信息
- 批准号:7998214
- 负责人:
- 金额:$ 59.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAccountingAddressAdipose tissueAdultAftercareAnthropometryArachidonic AcidsArchivesAreaBehavioralBiochemicalBiologicalBloodBody CompositionBody SizeBody WeightBody fatBody mass indexCancer BiologyCancer ControlCancer PrognosisCharacteristicsChemopreventionChicagoClinicClinicalClinical ProtocolsClinical assessmentsCohort StudiesCollectionDataDiagnosisDiagnosticDinoprostoneDiseaseEicosanoidsEnrollmentEpidemicEpidemiologyErythrocytesEstrogensExposure toFailureFatty AcidsFatty acid glycerol estersFutureGlandGonadal Steroid HormonesHealthHealth PersonnelHealth ProfessionalHealth behaviorHormonalHumanIL8 geneIllinoisImaging TechniquesImmunityImmunologic FactorsIndividualInflammationInsulin-Like Growth Factor IInsulin-Like Growth-Factor Binding Protein 1Insulin-Like-Growth Factor I ReceptorInterleukin-6InterventionKinesiologyLeptinLeukocytesLeukotriene B4Life StyleLightLinkMalignant neoplasm of prostateMeasuresMediatingMediationMediator of activation proteinMedical centerMedicineMetabolicMetabolismModelingMorbidity - disease rateNutritionalObesityOperative Surgical ProceduresOutcomeOverweightPathologicPathologistPathologyPathway interactionsPatientsPeriprostaticPharmaceutical ChemistryPhasePhysiologicalPhysiological ProcessesPlasmaPopulationPositioning AttributePrevalenceProstateProstate-Specific AntigenProstatectomyProstaticProteinsPublic HealthPublishingRadical ProstatectomyReceptor SignalingRelative (related person)ResearchRiskRisk FactorsScienceScientistSerumSignal PathwaySignaling ProteinSomatomedinsSourceSpecimenStagingStearic AcidsSurgical marginsTNF geneTarget PopulationsTestingTestosteroneTimeTissuesTreatment FactorUnited StatesUniversitiesUrologyVariantVisceralWeightabdominal fatadiponectinbasecancer recurrencecohortcytokinedesignlifestyle factorsmanmeetingsmenmonocytemortalitynutritionoutcome forecastpeptide hormonepreventprospectiverepositorytumortumor progression
项目摘要
DESCRIPTION (provided by applicant): This application attempts to clarify the mechanistic basis for the association between excessive adiposity and risk factors for prostate cancer-specific morbidity and mortality in men with clinically localized prostate cancer. The overall hypothesis is that excess adiposity alters prostatic exposure to nutritional, hormonal, and immunologic factors influenced by weight status and implicated in prostate cancer progression, and that inter- individual variation in gland-level exposure to these factors mediates the effects of adiposity on the pathologic presentation and course of the disease. To test this hypothesis, we will: Aim 1) conduct a prospective 2-year cohort study of incident cases of clinically localized prostate cancer to measure the association of adiposity with pathologic tumor features at diagnosis and 2-year risk of biochemical (PSA) failure after radical prostatectomy; Aim 2) measure fatty acids, insulin-like growth factor (IGF) axis activity, modulators of inflammation, and sex steroid hormone profiles in prostate tissue and periprostatic fat collected at surgery, and use mediation model analysis to determine which physiologic variables account for the effects adiposity on tumor characteristics and risk of biochemical failure; Aim 3) and evaluate the effects of post-treatment changes in adiposity on 2-year risk of biochemical failure. The cohort will consist of 540 men enrolled in the urology clinics of four Chicago-area medical centers who are awaiting prostatectomy for clinically localized prostate cancer. Adiposity will be quantified by anthropometry and dual energy x-ray absorptiometry at diagnosis and one year after surgery. Pathologic tumor characteristics will be determined by a single pathologist, and biochemical outcomes will be ascertained using a standard clinical protocol. Potential mediators to be studied include fatty acids, the IGF-1 receptor signaling pathway, adipose tissue-derived cytokines, eicosanoids products of arachidonic acid, and metabolites of estrogen and testosterone. Lifestyle factors that associate with more rapid progression of clinically early-stage prostate cancer are of increasing concern to health care providers and public health professionals. This research, to be completed over 5 years, will identify some of the biological reasons why obesity associates with more "aggressive" prostate cancer at diagnosis and decreases a man's chances for cure with surgery. It will also shed light on ways to prevent prostate cancer recurrence that may involve new or existing medicines or lifestyle changes. PUBLIC HEALTH RELEVANCE: Lifestyle factors that associate with more rapid progression of clinically early-stage prostate cancer are of increasing concern to health care providers and public health professionals. This research, to be completed over 5 years, will identify some of the biological reasons why obesity associates with more "aggressive" prostate cancer at diagnosis and decreases a man's chances for cure with surgery. It will also shed light on ways to prevent prostate cancer recurrence that may involve new or existing medicines or lifestyle changes.
描述(由申请人提供):本申请试图阐明临床局限性前列腺癌男性中过度肥胖与前列腺癌特异性发病率和死亡率的危险因素之间关联的机制基础。总体假设是,过度肥胖会改变前列腺对营养、激素和免疫因素的暴露,这些因素受体重状况影响,并与前列腺癌的进展有关,并且腺体水平暴露于这些因素的个体间差异介导了肥胖对前列腺癌的影响。病理表现和病程。为了检验这一假设,我们将: 目标 1) 对临床局限性前列腺癌的发病病例进行一项为期 2 年的前瞻性队列研究,以测量肥胖与诊断时肿瘤病理特征以及 2 年生化 (PSA) 失败风险之间的关系根治性前列腺切除术后;目标 2) 测量手术时收集的前列腺组织和前列腺周围脂肪中的脂肪酸、胰岛素样生长因子 (IGF) 轴活性、炎症调节剂和性类固醇激素谱,并使用中介模型分析来确定哪些生理变量可解释肥胖对肿瘤特征和生化失败风险的影响;目标 3) 并评估治疗后肥胖变化对 2 年生化失败风险的影响。该队列将由 540 名在芝加哥地区四个医疗中心的泌尿科诊所登记的男性组成,他们正在等待因临床局限性前列腺癌接受前列腺切除术。在诊断时和手术后一年,将通过人体测量学和双能 X 射线吸收测量法对肥胖进行量化。肿瘤病理特征将由一位病理学家确定,生化结果将使用标准临床方案确定。需要研究的潜在介质包括脂肪酸、IGF-1 受体信号通路、脂肪组织来源的细胞因子、花生四烯酸的类二十烷酸产物以及雌激素和睾酮的代谢产物。与临床早期前列腺癌更快进展相关的生活方式因素越来越受到医疗保健提供者和公共卫生专业人员的关注。这项研究将在五年内完成,将确定肥胖与诊断时更具“侵袭性”前列腺癌相关的一些生物学原因,并降低男性通过手术治愈的机会。它还将揭示预防前列腺癌复发的方法,可能涉及新的或现有的药物或生活方式的改变。公共卫生相关性:与临床早期前列腺癌更快进展相关的生活方式因素越来越受到医疗保健提供者和公共卫生专业人员的关注。这项研究将在五年内完成,将确定肥胖与诊断时更具“侵袭性”前列腺癌相关的一些生物学原因,并降低男性通过手术治愈的机会。它还将揭示预防前列腺癌复发的方法,可能涉及新的或现有的药物或生活方式的改变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vincent L Freeman其他文献
Vincent L Freeman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vincent L Freeman', 18)}}的其他基金
Adiposity and Outcomes of Clinically Localized Prostate Cancer
肥胖和临床局限性前列腺癌的结果
- 批准号:
7754086 - 财政年份:2009
- 资助金额:
$ 59.25万 - 项目类别:
Adiposity and Outcomes of Clinically Localized Prostate Cancer
肥胖和临床局限性前列腺癌的结果
- 批准号:
8388780 - 财政年份:2009
- 资助金额:
$ 59.25万 - 项目类别:
Adiposity and Outcomes of Clinically Localized Prostate Cancer
肥胖和临床局限性前列腺癌的结果
- 批准号:
8196997 - 财政年份:2009
- 资助金额:
$ 59.25万 - 项目类别:
Adiposity and Outcomes of Clinically Localized Prostate Cancer
肥胖和临床局限性前列腺癌的结果
- 批准号:
7581244 - 财政年份:2009
- 资助金额:
$ 59.25万 - 项目类别:
Addressing Racial Disparities in Prostate and Colorectal Cancer in Chicago
解决芝加哥前列腺癌和结直肠癌的种族差异
- 批准号:
8353384 - 财政年份:
- 资助金额:
$ 59.25万 - 项目类别:
相似国自然基金
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
异常获利、捐赠与会计信息操纵:基于新冠疫情的准自然实验研究
- 批准号:72372061
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
相似海外基金
Artificial Intelligence powered virtual digital twins to construct and validate AI automated tools for safer MR-guided adaptive RT of abdominal cancers
人工智能支持虚拟数字双胞胎来构建和验证人工智能自动化工具,以实现更安全的 MR 引导的腹部癌症自适应放疗
- 批准号:
10736347 - 财政年份:2023
- 资助金额:
$ 59.25万 - 项目类别:
Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma
纤维化的分子成像改善胰腺导管腺癌的治疗计划
- 批准号:
10656169 - 财政年份:2022
- 资助金额:
$ 59.25万 - 项目类别:
Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma
纤维化的分子成像改善胰腺导管腺癌的治疗计划
- 批准号:
10370616 - 财政年份:2022
- 资助金额:
$ 59.25万 - 项目类别:
Patient-Centered Outcomes of Sacrocolpopexy versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse
以患者为中心的骶阴道固定术与子宫骶韧带悬吊术治疗子宫阴道脱垂的结果
- 批准号:
10279888 - 财政年份:2021
- 资助金额:
$ 59.25万 - 项目类别:
Patient-Centered Outcomes of Sacrocolpopexy versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse
以患者为中心的骶阴道固定术与子宫骶韧带悬吊术治疗子宫阴道脱垂的结果
- 批准号:
10674781 - 财政年份:2021
- 资助金额:
$ 59.25万 - 项目类别: